⌘K

Home/Filings/4/0001209191-21-002371

4//SEC Filing

Maloberti Renaud Bertrand 4

Accession 0001209191-21-002371

CIK 0001681682other

View on SEC.gov Company Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 7:15 PM ET

Size

4.9 KB

Accession

0001209191-21-002371

Insider Transaction Report

Form 4

Period: 2021-01-06

ENDRA Life Sciences Inc.NDRA

Maloberti Renaud Bertrand

Chief Commercial Officer

Transactions

Sale
Common Stock
2021-01-06$0.94/sh−11,269$10,593→ 30,311 total

Footnotes (1)

[F1]Represents shares sold pursuant to a 10b5-1 trading plan to pay withholding taxes due in connection with the vesting of certain restricted stock units.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1

filerCIK 0001744025

Filing Metadata

Form type: 4
Filed: Jan 5, 7:00 PM ET
Accepted: Jan 6, 7:15 PM ET
Size: 4.9 KB

View on SEC.gov